QMLGMLOct 29, 2018

From Gene Expression to Drug Response: A Collaborative Filtering Approach

arXiv:1810.12758v26 citations
Originality Incremental advance
AI Analysis

This work addresses the problem of personalized drug response prediction for cancer patients, which is incremental as it builds on existing collaborative filtering and matrix factorization techniques.

The authors tackled the problem of predicting cancer cell drug responses from gene expression data, which is challenging due to the high dimensionality of features relative to sample size. They proposed a collaborative filtering-based method using low-rank matrix factorization and latent linear regression, achieving better prediction of drug-gene associations than state-of-the-art methods on the Genomics of Drug Sensitivity in Cancer database.

Predicting the response of cancer cells to drugs is an important problem in pharmacogenomics. Recent efforts in generation of large scale datasets profiling gene expression and drug sensitivity in cell lines have provided a unique opportunity to study this problem. However, one major challenge is the small number of samples (cell lines) compared to the number of features (genes) even in these large datasets. We propose a collaborative filtering (CF) like algorithm for modeling gene-drug relationship to identify patients most likely to benefit from a treatment. Due to the correlation of gene expressions in different cell lines, the gene expression matrix is approximately low-rank, which suggests that drug responses could be estimated from a reduced dimension latent space of the gene expression. Towards this end, we propose a joint low-rank matrix factorization and latent linear regression approach. Experiments with data from the Genomics of Drug Sensitivity in Cancer database are included to show that the proposed method can predict drug-gene associations better than the state-of-the-art methods.

Foundations

The foundational work for this paper's niche, ranked by how specifically the neighbourhood builds on it — not by global fame.

Your Notes